Percutaneous coronary intervention versus coronary artery bypass graft in chronic kidney disease: Optimal treatment options

Hemodialysis International

Volumn 15, Issue SUPPL. 1, 2011, Pages

  Kar, Subrata ^a,b   Coats, Walter ^a,b   Aggarwal, Kul ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chronic renal failure; Coronary artery bypass; Coronary artery disease; Percutaneous coronary intervention; Stents

Indexed keywords

ANGINA PECTORIS; ARTICLE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY BYPASS GRAFT; HUMAN; MEDICAL RECORD REVIEW; MEDLINE; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; SURVIVAL TIME;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; HUMANS; MALE; RENAL INSUFFICIENCY, CHRONIC; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80054891323     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2011.00599.x     Document Type: Article

References (22)

1. Yang J, Li J, Lu C, Hasimu B, Yang Y, Hu D. Chronic kidney disease, all-cause mortality and cardiovascular mortality among Chinese patients with established cardiovascular disease. J Atheroscler Thromb. 2010; 17:395-401.
2. Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Seminary Dial. 2003; 16:101-105.
3. DeLima JJG, Gowdak LHW, Jota de Paula F, etal. Treatment of coronary artery disease in hemodialysis patients evaluated for transplant-A registry study. Transplantation. 2010; 89:845-850.
4. Kidney Disease Outcomes Quality Initiative. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007; 49:S12-154.
5. Taggart DP. Coronary artery bypass graft vs. percutaneous coronary angioplasty: CABG on the rebound? Curr Opin Cardiol. 2007; 22:517-523.
6. King SB, Marshall JJ, Tummala PE. Revascularization for coronary artery disease: Stents versus bypass surgery. Annu Rev Med. 2010; 61:199-213.
7. Gibbons RJ, Fihn SD. Coronary revascularization: New evidence, new challenges. Ann Intern Med. 2007; 147:732-734.
8. Franchi E, Marino P, Biondi-Zoccai GG, DeLuca G, Vassanelli C, Agostoni P. Transradial versus transfemoral approach for percutaneous coronary procedures. Curr Cardiol Rep. 2009; 11:391-397.
9. O'Hanlon R, Reddan DN. Treatment of acute coronary syndromes in patients who have chronic kidney disease. Med Clin North Am. 2005; 89:563-585.
10. Sedlis SP, Jurkovitz CT, Hartigan PM, etal. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease. Am J Cardiol. 2009; 104:1647-1653.
11. Chonchol M, Whittle J, Desbien A, Orner MB, Petersen LA, Kressin NR. Chronic kidney disease is associated with angiographic coronary artery disease. Am J Nephrol. 2008; 28:354-360.
12. Hemmelgarn BR, Southern D, Culleton BF, Mitchell LB, Knudtson ML, Ghali WA. Survival after coronary revascularization among patients with kidney disease. Circulation. 2004; 110:1890-1895.
13. Ix JH, Mercado N, Shlipak MG, etal. Association of chronic kidney disease with clinical outcomes after coronary revascularization: The Arterial Revascularization Therapies Study (ARTS). Am Heart J. 2005; 149:512-519.
14. Sunagawa G, Komiya T, Tamura N, Sakaguchi G, Kobayashi T, Murashita T. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis. Ann Thorac Surg. 2010; 89:1896-1900.
15. Manabe S, Shimokawa T, Fukui T, etal. Coronary artery bypass surgery versus percutaneous coronary intervention in patients on chronic hemodialysis: Does a drug-eluting stent have an impact on clinical outcome? J Card Surg. 2009; 24:234-239.
16. Ashrith G, Lee VV, Elayda MA, Reul R, Wilson JM. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease. Am J Cardiol. 2010; 106:348-353.
17. Wang ZJ, Zhou YJ, Liu YY, etal. Comparison of drug-eluting stents and coronary artery bypass grafting for the treatment of multivessel coronary artery disease in patients with chronic kidney disease. Circ J. 2009; 73:1228-1234.
18. Nakazawa G, Tanabe K, Aoki J, etal. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary interventions with sirolimus-eluting stents. Catheter Cardiovasc Interv. 2007; 69:808-814.
19. Gruberg L, Dangas G, Mehran R, etal. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv. 2002; 55:66-72.
20. Ishio N, Kobayashi T, Takebayashi H, etal. Impact of drug-eluting stents on clinical and outcomes in dialysis patients. J Circ. 2007; 71:1525-1529.
21. Aoyama T, Ishii H, Toriyama T, etal. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J. 2008; 72:56-60.
22. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 2002; 106:2207-2211.